BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

527 related articles for article (PubMed ID: 34489709)

  • 1. RNA Methylations in Cardiovascular Diseases, Molecular Structure, Biological Functions and Regulatory Roles in Cardiovascular Diseases.
    Zhou W; Wang C; Chang J; Huang Y; Xue Q; Miao C; Wu P
    Front Pharmacol; 2021; 12():722728. PubMed ID: 34489709
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The molecular structure and biological functions of RNA methylation, with special emphasis on the roles of RNA methylation in autoimmune diseases.
    Zhou W; Wang X; Chang J; Cheng C; Miao C
    Crit Rev Clin Lab Sci; 2022 May; 59(3):203-218. PubMed ID: 34775884
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emerging roles of RNA methylation in gastrointestinal cancers.
    Xie S; Chen W; Chen K; Chang Y; Yang F; Lin A; Shu Q; Zhou T; Yan X
    Cancer Cell Int; 2020 Dec; 20(1):585. PubMed ID: 33372610
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mapping the m1A, m5C, m6A and m7G methylation atlas in zebrafish brain under hypoxic conditions by MeRIP-seq.
    Li W; Li X; Ma X; Xiao W; Zhang J
    BMC Genomics; 2022 Feb; 23(1):105. PubMed ID: 35135476
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Involvement of RNA methylation modification patterns mediated by m7G, m6A, m5C and m1A regulators in immune microenvironment regulation of Sjögren's syndrome.
    Liu Y; Zhu J; Ding L
    Cell Signal; 2023 Jun; 106():110650. PubMed ID: 36935085
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An m6A/m5C/m1A/m7G-Related Long Non-coding RNA Signature to Predict Prognosis and Immune Features of Glioma.
    Shao D; Li Y; Wu J; Zhang B; Xie S; Zheng X; Jiang Z
    Front Genet; 2022; 13():903117. PubMed ID: 35692827
    [No Abstract]   [Full Text] [Related]  

  • 7. N6-Methyladenosine RNA Methylation in Cardiovascular Diseases.
    Liu C; Gu L; Deng W; Meng Q; Li N; Dai G; Yu S; Fang H
    Front Cardiovasc Med; 2022; 9():887838. PubMed ID: 35571209
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of m6A RNA methylation in cardiovascular disease (Review).
    Qin Y; Li L; Luo E; Hou J; Yan G; Wang D; Qiao Y; Tang C
    Int J Mol Med; 2020 Dec; 46(6):1958-1972. PubMed ID: 33125109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The lncRNA epigenetics: The significance of m6A and m5C lncRNA modifications in cancer.
    Cusenza VY; Tameni A; Neri A; Frazzi R
    Front Oncol; 2023; 13():1063636. PubMed ID: 36969033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. mRNA modifications in cardiovascular biology and disease: with a focus on m6A modification.
    Kumari R; Ranjan P; Suleiman ZG; Goswami SK; Li J; Prasad R; Verma SK
    Cardiovasc Res; 2022 Jun; 118(7):1680-1692. PubMed ID: 33956076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RNA methylations in depression, from pathological mechanism to therapeutic potential.
    Li C; Xu P; Huang Y; Wang Y; Wu Y; Li H; Peng Y; Wang X; Li G; He J; Miao C
    Biochem Pharmacol; 2023 Sep; 215():115750. PubMed ID: 37595670
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emerging role of m
    Peng L; Long T; Li F; Xie Q
    Cell Biol Int; 2022 May; 46(5):711-722. PubMed ID: 35114043
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of RNA methylation in tumor immunity and its potential in immunotherapy.
    Li Y; Jin H; Li Q; Shi L; Mao Y; Zhao L
    Mol Cancer; 2024 Jun; 23(1):130. PubMed ID: 38902779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RNA Modifications and Epigenetics in Modulation of Lung Cancer and Pulmonary Diseases.
    Teng PC; Liang Y; Yarmishyn AA; Hsiao YJ; Lin TY; Lin TW; Teng YC; Yang YP; Wang ML; Chien CS; Luo YH; Chen YM; Hsu PK; Chiou SH; Chien Y
    Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638933
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Roles of RNA Methylations in Cancer Progression, Autophagy, and Anticancer Drug Resistance.
    Jo H; Shim K; Jeoung D
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835633
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RM2Target: a comprehensive database for targets of writers, erasers and readers of RNA modifications.
    Bao X; Zhang Y; Li H; Teng Y; Ma L; Chen Z; Luo X; Zheng J; Zhao A; Ren J; Zuo Z
    Nucleic Acids Res; 2023 Jan; 51(D1):D269-D279. PubMed ID: 36300630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reversible N6-methyladenosine of RNA: The regulatory mechanisms on gene expression and implications in physiology and pathology.
    Fang X; Li M; Yu T; Liu G; Wang J
    Genes Dis; 2020 Dec; 7(4):585-597. PubMed ID: 33335958
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insights into the regulatory role of RNA methylation modifications in glioma.
    Long S; Yan Y; Xu H; Wang L; Jiang J; Xu Z; Liu R; Zhou Q; Huang X; Chen J; Li Z; Wei W; Li X
    J Transl Med; 2023 Nov; 21(1):810. PubMed ID: 37964279
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RNAWRE: a resource of writers, readers and erasers of RNA modifications.
    Nie F; Feng P; Song X; Wu M; Tang Q; Chen W
    Database (Oxford); 2020 Jan; 2020():. PubMed ID: 32608478
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epitranscriptomic Regulations in the Heart.
    Benak D; Kolar F; Hlavackova M
    Physiol Res; 2024 Apr; ():. PubMed ID: 38634649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.